# Shenzhen Xinkairui Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-xinkairui-biotechnology

- Industry: Healthcare IT
- Headquarters: Shenzhen, China
- Latest round: Series A (Dec 28, 2019)
- Investors on record: 2

## About

Established in 2017 and based in Shenzhen, China, Shenzhen Xinkairui Biotechnology operates as a fluorescent detection platform dedicated to providing in vitro diagnostic instruments and reagents. In December 2019, the company closed series A funding led by new investor Mefund Capital.

The company mainly provides in vitro diagnostic instruments and reagents. 

The company generates revenue by providing in vitro diagnostic instruments and reagents.

## Funding rounds

- Series A, Dec 28, 2019 — Shenzhen Investment Holdings, MED-FINE Capital

## Investors

- Shenzhen Investment Holdings — Series A
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series A